Horn L C, Bilek K
Institute of Pathology, University Hospital of Leipzig, Germany.
Pathol Res Pract. 1995 Oct;191(10):991-6. doi: 10.1016/s0344-0338(11)80597-2.
Heterotopic tissue in lymph nodes is rare. Benign glandular lymph node inclusions (BGI) occur in 11.4% on average. Their histogenesis is still obscure. We studied 34 out of 1,039 cases of retroperitoneal lymph nodes with BGI (3.35%) of women who were treated by radical hysterectomy by Wertheim-Meigs of a cervical carcinoma. The nodes were reexamined by light microscopy and in 19 cases the antibodies MAK 6 (cytokeratine cocktail), HEA 125, Ber EP-4 (for differentiation between mesothelium and glandular differentiation), vimentin and CEA were additionally used. All BGI showed a strong expression of MAK 6 and in 57.9% and 73.7% to HEA 125 and Ber EP-4, respectively. Positive reaction against vimentin occured in 47.3%, but often only single cells were positive. None but one metastasis of an endometrioid adenocarcinoma of the cervix uteri of BGI expressed CEA. The BGI showed a capsular, trabecular or interfollicular location in more than 80% and in 44.1% an admixture of several cells at the lining epithelium was noted. No features usually associated with endometriosis, such as periglandular stroma or evidence of recent or old hemorrhage were seen. The results suggest that the BGI represent an endosalpingiosis and is therefore of secondary Müllerian origin. Some light microscopic features favoring the benign origin (location in the nodes, lining cells of multiple types, lack of mitoses and cellular atypism, no desmoplastic stroma reaction, presence of periglandular basement membrane) may be helpful in distinguishing metastasis of serous ovarian borderline tumors. Negative reaction against CEA and the cellular morphology can preclude metastases of an endometrioid adenocarcinoma of the cervix uteri as well as of a mucinous ovarian borderline tumor.
淋巴结中的异位组织较为罕见。良性腺性淋巴结包涵体(BGI)的平均发生率为11.4%。其组织发生机制仍不清楚。我们研究了1039例接受Wertheim-Meigs根治性子宫切除术治疗宫颈癌的女性患者中的34例腹膜后淋巴结伴有BGI(3.35%)的病例。对这些淋巴结进行了光镜复查,19例病例还额外使用了MAK 6(细胞角蛋白混合物)、HEA 125、Ber EP-4(用于间皮与腺性分化的鉴别)、波形蛋白和癌胚抗原(CEA)抗体。所有BGI均显示MAK 6强表达,分别有57.9%和73.7%的BGI对HEA 125和Ber EP-4呈阳性反应。波形蛋白阳性反应发生率为47.3%,但通常仅单个细胞呈阳性。除1例子宫颈内膜样腺癌转移外,BGI均不表达CEA。BGI在超过80%的病例中位于包膜、小梁或滤泡间,44.1%的病例在衬里上皮可见多种细胞混合。未见通常与子宫内膜异位症相关的特征,如腺周间质或近期或陈旧性出血的证据。结果表明,BGI代表输卵管内膜异位,因此起源于副中肾管。一些支持良性起源的光镜特征(位于淋巴结内、多种类型的衬里细胞、无核分裂及细胞异型性、无促纤维组织增生性间质反应、存在腺周基底膜)可能有助于鉴别浆液性卵巢交界性肿瘤的转移。CEA阴性反应及细胞形态可排除子宫颈内膜样腺癌及黏液性卵巢交界性肿瘤的转移。